NOVONESIS A/S NAM. B DK 2
NOVONESIS A/S NAM. B DK 2/ DK0060336014 /
NZM2
|
25.06.2024 19:30:58
|
Zm.
+0,24
|
Wolumen |
Bid19:31:02 |
Ask19:31:02 |
Kapitalizacja Rynkowa |
St. dywidendy |
Wskaźnik C/Z |
|
57,66EUR
|
+0,42%
|
0
Obrót: 0.00 |
-Wolumen Bid: - |
-Wolumen Ask: - |
16,16 mldEUR |
- |
- |
Opis działalności
Novozymes is the world leader in biological solutions. As the world’s largest provider of enzyme and microbial technologies, the company´s bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel and many other benefits.
Zarząd & Rada nadzorcza
| CEO |
| Ester Baiget |
| Zarząd |
| Rainer Lehmann, Amy Byrick, Anders Lund, Claus Crone Fuglsang, Graziela Chaluppe dos Santos Malucelli, Morten Enggaard Rasmussen, Tina Sejersgård Fanø |
| Rada nadzorcza |
| Cees de Jong, Andreas Hentze Knudsen, Anne Breum, Cees de Jong, Heine Dalsgaard, Jens Øbro, Kasim Kutay, Kim Stratton, Mathias Uhlén, Preben Nielsen, Sharon James |
Dane firmy
| Nazwa: |
Novozymes A.S |
| Adres: |
Krogshoejvej 36,DK-2880 Bagsvaerd |
| Telefon: |
+45-44-460000 |
| Fax: |
- |
| E-mail: |
-
|
| Internet: |
www.novozymes.com/ |
| Przemysł: |
Biotechnologia |
| Sektor: |
Biotechnologia |
| Podsektor: |
Biotechnologia |
| Koniec roku finansowego: |
31.12 |
| Free float: |
74,50% |
| Data IPO: |
20.11.2000 |
